Baker Institute Viewpoints on Prescription Drugs

As policymakers grapple with how to address the growing problem of prescription drug abuse — including a quiet reassessment of U.S. policies that focus on keeping illegal drugs out of the country — drug policy experts at the Baker Institute ask: What does rising prescription drug abuse mean for the “war on drugs”?

Nonresident drug policy fellow Gary Hale, former chief of intelligence in the Houston Field Division of the Drug Enforcement Administration, leads off this three-day installment of Baker Institute Viewpoints by laying out the scope of the problem.

In the second of three posts in this installment, Tony Payan, the visiting Baker Institute Scholar for Border and Immigration Studies, examines how our approach to prescription drug abuse can inform how the U.S. deals with illegal drugs.

Nathan Jones, the institute’s Alfred C. Glassell III Postdoctoral Fellow in Drug Policy, wraps up this installment of Baker Institute Viewpoints with a look at the impact of prescription pill abuse on Mexican drug cartels.

Source: Baker Institute – December 3-5, 2012